The group is on the cusp of rolling out its CardioQ oesophageal Doppler monitoring (ODM) device on a large scale, and this tender is the latest in a recent string of endorsements for the technology by UK and international health bodies.

National Milk Records is looking to new pastures for growth to build on its already commanding position in Britain’s dairy industry.

The National Health Service’s chief executive has published his intention to instruct the organisation to implement fluid management during surgery using oesophageal Doppler monitoring technogy as a priority. Deltex believes the news is significant for sales of its CardioQ-ODM device

The firm continues to do well with increased sales of its blood monitoring system in the UK, while it is also pursuing opportunities to build recurring revenues in Canada, Scandinavia and Australia

African Medical Investments’ new chief executive Peter Botha is upbeat on prospects for the provider of international standard healthcare to groups including the rapidly expanding African middle classes. His key near term-term objectives, as revealed in the full year statement today, include cutting costs and boosting revenue to help move  the group into cashflow positive territory by the first quarter of 2012.

Less than a month into his tenure, the new boss, Peter Botha is already making his mark. Here we speak to Botha about his plan to cut costs by 25 per cent and boost revenues, which should ensure the hospitals group is cash flow positive early next year. 

New chief executive Peter Botha sees a huge opportunity in Africa’s emerging healthcare industry. Botha was hired last Tuesday, to take the reins at a crucial time for the company as it tries to draw a line in the sand and put the group’s tumultuous recent history behind it.

Four separate clinical studies appear to endorse the use of oesophageal doppler monitoring during surgery, lending heavyweight support to the pioneering CardioQ-ODM device created by Deltex Medical Group.

When we last profiled medical device manufacturer Deltex Medical Group in June last year, the shares were trading for around 10.5 pence each. Today, they are some 150% higher at 25.75p. Proactive Investors investigates...

Some of the market’s major winners will be companies that offer palpable cost savings to under-pressure public sector. A case in point is Deltex Medical, which has a device called CaridioQ that could save the National Health Service an estimated £1 billion a year.

The group plans a major overhaul of its share register to boost the liquidity and attract new investors. The current register of 24,500 shareholders - stemming from shares being issued to around 28,000 British dairy farmers following the disbanding of the Milk Marketing Board - is to be massively reduced.

Here we look at Advanced Medical Solutions, a wound-care company that is profitable and plans to pay a dividend. Chief executive Don Evans talks about super-glue, silver and his plans to expand in America. 

African Medical Investments confirmed this morning that criminal charges for fraud and theft have been brought in South Africa against former chief executive Vivek Solanki and manager Wessel Roets.

The progress of Lombard Medical Technologies (LON: LMMT) has been ‘excellent’ since it concluded its re-financing on February 1, according to chief executive John Rush.

Deltex’s main product is the CardioQ-ODM system which changes the way that doctors care for patients undergoing surgical procedures, helping the patients to recover faster and enabling them to leave hospital sooner

In June 2009, the collapse of the Dairy Farmers of Britain took some by surprise, but for many within the industry it was a sign of the times: only competitive and efficient milk producers can survive.

African Medical said the deal underscored the “considerable traction” it was gaining it its target audiences, particularly in the medical insurance market which it said would be increasingly important for the company.

While the progress with negotiating new facilities in new target cities and increasing the number of patients has been “tremendous,” the most significant highlight of the year was this month’s equity line agreement with Harbinger Capital

With the world’s equity markets displaying the kind of volatility we have observed in the last twelve months, it is no wonder that investors are looking for safety in places traditionally considered less volatile

Monitoring of the key cardiovascular parameters – blood pressure, cardiac output and oxygen delivery – can provide a practical, early warning of cardiovascular change and potential adverse events in surgery